Niklas Paul Grusdat1, Alexander Stäuber1, Marion Tolkmitt2, Jens Schnabel2, Birgit Schubotz3, Henry Schulz1. 1. Professorship of Sports Medicine/Sports Biology, Chemnitz University of Technology, Chemnitz, Germany. 2. Deutsches Rotes Kreuz Krankenhaus Chemnitz-Rabenstein, German Red Cross Hospital, Chemnitz, Germany. 3. Tumorzentrum Chemnitz e.V., Clinical Cancer Registry Chemnitz, Chemnitz, Germany.
Abstract
INTRODUCTION: Breast cancer can be a major challenge for those affected. Knowledge of changes in fine motor dexterity in affected women due to routine cancer therapies can help guide effective support. METHODS: For this prospective observational study, we collected data of 79 women with a mean age 54.6 ± 9.5 years prior to, after breast cancer therapy (T1), and at 3-month follow-up. The fine motor dexterity was assessed for 4 treatment subgroups: SC = Surgery + Chemotherapy, SCR = Surgery + Chemotherapy + Radiotherapy Therapy, SR = Surgery + Radiotherapy, and S = Surgery. RESULTS: Over time, women with breast cancer showed significant decreases in fine motor dexterity across all treatment groups (p < 0.001). The strongest negative effect was seen in the treatment groups receiving additional chemotherapy. SCR group showed pronounced limitations for dominant hand (DH) -12%; non-dominant hand (NDH) -15%; both hands (BH) -17%; assembly (ASSY) -11% at T1. Significant interaction was noticeable in DH (F = 5.59, p < 0.001), NDH (F = 6.61, p < 0.001), BH (F = 13.11 p < 0.001), and ASSY (F = 5.84 p < 0.001). DISCUSSION/ CONCLUSION: Our study showed that the extent of change in fine motor dexterity depends on the treatment regimen. The detection of unmet care needs could help to personalize and optimize clinical and survivorship care. Based on our findings, multidisciplinary support initiated early in breast cancer therapy is required. The Author(s). Published by S. Karger AG, Basel.
INTRODUCTION: Breast cancer can be a major challenge for those affected. Knowledge of changes in fine motor dexterity in affected women due to routine cancer therapies can help guide effective support. METHODS: For this prospective observational study, we collected data of 79 women with a mean age 54.6 ± 9.5 years prior to, after breast cancer therapy (T1), and at 3-month follow-up. The fine motor dexterity was assessed for 4 treatment subgroups: SC = Surgery + Chemotherapy, SCR = Surgery + Chemotherapy + Radiotherapy Therapy, SR = Surgery + Radiotherapy, and S = Surgery. RESULTS: Over time, women with breast cancer showed significant decreases in fine motor dexterity across all treatment groups (p < 0.001). The strongest negative effect was seen in the treatment groups receiving additional chemotherapy. SCR group showed pronounced limitations for dominant hand (DH) -12%; non-dominant hand (NDH) -15%; both hands (BH) -17%; assembly (ASSY) -11% at T1. Significant interaction was noticeable in DH (F = 5.59, p < 0.001), NDH (F = 6.61, p < 0.001), BH (F = 13.11 p < 0.001), and ASSY (F = 5.84 p < 0.001). DISCUSSION/ CONCLUSION: Our study showed that the extent of change in fine motor dexterity depends on the treatment regimen. The detection of unmet care needs could help to personalize and optimize clinical and survivorship care. Based on our findings, multidisciplinary support initiated early in breast cancer therapy is required. The Author(s). Published by S. Karger AG, Basel.
Entities:
Keywords:
Breast cancer; Cancer treatment; Fine motor dexterity; Survivorship
Authors: Donna R Rivera; Patricia A Ganz; Meghan S Weyrich; Hanna Bandos; Joy Melnikow Journal: J Natl Cancer Inst Date: 2018-02-01 Impact factor: 13.506
Authors: Hannah C Timmins; Tiffany Li; Matthew C Kiernan; Sally Baron-Hay; Gavin Marx; Frances Boyle; David Goldstein; Susanna B Park Journal: Support Care Cancer Date: 2020-01-11 Impact factor: 3.603
Authors: Christine Miaskowski; Judy Mastick; Steven M Paul; Kimberly Topp; Betty Smoot; Gary Abrams; Lee-May Chen; Kord M Kober; Yvette P Conley; Margaret Chesney; Kay Bolla; Grace Mausisa; Melissa Mazor; Melisa Wong; Mark Schumacher; Jon D Levine Journal: J Pain Symptom Manage Date: 2017-01-04 Impact factor: 3.612
Authors: M R Ten Tusscher; W G Groen; E Geleijn; G S Sonke; I R Konings; M J Van der Vorst; A van Zweeden; N K Aaronson; Martijn M Stuiver Journal: Support Care Cancer Date: 2019-01-04 Impact factor: 3.603
Authors: Catherine Lehoux; James Everett; Louis Laplante; Claudia Emond; Johanne Trépanier; Andrée Brassard; Linda René; Mireille Cayer; Chantal Mérette; Michel Maziade; Marc André Roy Journal: Schizophr Res Date: 2003-08-01 Impact factor: 4.939
Authors: Angelica E Lang; Clark R Dickerson; Soo Y Kim; Jamie Stobart; Stephan Milosavljevic Journal: Clin Biomech (Bristol, Avon) Date: 2019-10-19 Impact factor: 2.063
Authors: Kimberly D van der Willik; Vincent Koppelmans; Michael Hauptmann; Annette Compter; M Arfan Ikram; Sanne B Schagen Journal: Breast Cancer Res Date: 2018-11-15 Impact factor: 6.466